Merck & Co. Inc. (MRK) Social Stream



Merck & Co. Inc. (MRK): $91.22

-1.20 (-1.30%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Merck & Co Inc (MRK) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Merck & Co Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 13 $110 $79 $95.272 $82.4 15.62%
2021-11-19 13 $110 $79 $94.916 $82.4 15.19%
2021-11-23 13 $110 $79 $95.166 $82.4 15.49%
2021-11-29 14 $110 $79 $93.692 $82.4 13.7%
2021-12-09 16 $110 $79 $93.428 $82.4 13.38%
2021-12-13 17 $110 $76 $92.266 $82.4 11.97%
2022-01-24 17 $110 $70 $90.875 $82.4 10.29%
2022-02-04 17 $110 $70 $90.562 $82.4 9.91%
2022-03-08 17 $110 $70 $90.5 $82.4 9.83%

The Trend in the Analyst Price Target


Over the past 21 months, MRK's average price target has gone down $2.77.

Over the past 48 weeks, MRK's average upside potential has been 21.32%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-01 26 107 80 93.110 76.87 21.13%
2021-09-11 26 107 80 93.210 73.45 26.9%
2021-11-08 12 110 79 95.272 82.68 15.23%
2021-11-19 13 110 79 94.916 80.70 17.62%
2021-12-23 17 110 70 90.875 75.73 20%

MRK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.06 8 0 9 0 0 17

The Trend in the Broker Recommendations


MRK's average broker recommendation rating improved by 0 over the prior 90 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Merck & Co Inc's number of analysts covering the stock is greater than 1112.96% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Merck & Co Inc's upside potential (average analyst target price relative to current price) is higher than 92.23% of them.
  • In terms of how Merck & Co Inc fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1103.4% of that group.
  • In the context of Pharmaceutical Products stocks, Merck & Co Inc's variance in analysts' estimates is lower than -279.14% of them.

In the Pharmaceutical Products industry, LLY, JNJ, and ABT are the three stocks most similar to Merck & Co Inc regarding the price target and analyst recommendation information presented here.

Is MRK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4523 seconds.